Skip to main content
Clinical Trials/NCT04018898
NCT04018898
Completed
Not Applicable

Older Emergency Department Users and Short-term Adverse Events at the Index Visit: Which Clinical Prognostic Tool is Used?

Jewish General Hospital1 site in 1 country10,971 target enrollmentJuly 23, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Health Impairment
Sponsor
Jewish General Hospital
Enrollment
10971
Locations
1
Primary Endpoint
Short-term adverse events
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study evaluates the difference between PRISMA-7 and ER2 tool. There are some differences between PRISMA-7 and ER2 tool. The differences consist in evaluation criteria that are used to perform the both surveys. We suppose that evaluation criteria of PRISMA-7 is not accurately enough to calculate the length of hospital stay and to predict the short-term outcomes.

Detailed Description

The "Program of Research on Integration of Services for the Maintenance of Autonomy" (PRISMA-7) is the Ministry of Health and Social Services' reference tool for the assessment of older ED users in Quebec (Canada). PRISMA-7 has been initially designed to screen disability in community-dwelling older adults and has never been validated for risk for short-term adverse events in older ED users. "Emergency room evaluation and recommendations" (ER2) is another clinical tool which is currently evaluated in Quebec. Compared to PRISMA-7, ER2 has been especially designed for assessing risk for short-term ED adverse events. No study has compared PRISMA-7 and ER2 risk for short-term adverse events. We hypothesised that ER2 could be a better prognostic tool compared to PRISMA-7 for long length of stay in ED and hospital stay, and hospital admission because it was designed and validated for this specific goal. The study aims to 1) examine and compared PRISMA-7 and ER2 risk for long length of ED and hospital stay and hospital admission, and 2) to establish their performance criteria (i.e., sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratios) for these three short-term adverse events in older ED users.

Registry
clinicaltrials.gov
Start Date
July 23, 2019
End Date
July 1, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Olivier Beauchet

MD, Professor of Geriatrics

Jewish General Hospital

Eligibility Criteria

Inclusion Criteria

  • Being 75 years old and over
  • Brought at Emergency on medical stretcher

Exclusion Criteria

  • Being less than 75 years old
  • Never come at Emergency

Outcomes

Primary Outcomes

Short-term adverse events

Time Frame: Around 10 months

The adverse event is defined as an adverse outcome related to an ED encounter, this adverse event is related to ED care.

Study Sites (1)

Loading locations...

Similar Trials